Long COVID After Bamlanivimab Treatment

By sjmartinez • August 31, 2023

Evering TH, Moser CB, Jilg N, Yeh E, Sanusi B, Wohl DA, Daar ES, Li JZ, Klekotka P, Javan AC, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW; ACTIV-2/A5401 Study Team. Long COVID After Bamlanivimab Treatment. J Infect Dis. 2023 Aug 31;228(Supplement_2):S126-S135. doi: 10.1093/infdis/jiad286. PMID: 37650236.

Tags: bamlanivimab, Clinical Trial, Harbor UCLA, Infectious Diseases, long COVID, postacute sequelae of SARS-CoV-2 infection (PASC), Publications, symptom

Host targets of candidalysin

Lin J, Filler SG. Host targets of candidalysin. PLoS Pathog. 2025 Jun 23;21(6):e1013284. doi: 10.1371/journal.ppat.1013284. PMID: 40549807; PMCID: PMC12184922.

TRANSLATING THE MECHANISMS OF HYPOXIA TO LONG-TERM OXYGEN PRESCRIPTION IN COPD: A PROPOSAL

Lacasse Y, Joseph V, Casaburi R, Maltais F. TRANSLATING THE MECHANISMS OF HYPOXIA TO LONG-TERM OXYGEN PRESCRIPTION IN COPD: A PROPOSAL. Chest. 2025 Jun 17:S0012-3692(25)00697-X.[...]

The Impact of Artificial Intelligence on Women’s Cardiovascular Disease Care

Chung J, Thangathurai J, Andrade-Bucknor S, Parashar S, Carta KG, Epp M, Ma C. The Impact of Artificial Intelligence on Women's Cardiovascular Disease Care. Curr[...]